-
Mashup Score: 1
Background: The incidence of squamous cell carcinoma of the anus (SCCA) is increasing, particularly among the elderly (age ≥65 years). We sought to compare patterns of care for the treatment of SCCA in elderly versus nonelderly patients. Methods: Data for patients with stages I–III SCCA diagnosed from 2004 through 2015 were obtained from the National Cancer Database. Patients were categorized as…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for all GI Cancers? - 2 year(s) ago
Use of germline genetic testing among patients with cancer is increasing because of (1) the availability of multigene panel tests that include multiple cancer susceptibility genes in a single test, (2) decreased costs of these tests and improvements in insurance coverage, and (3) US Food and Drug Administration–approval of genotype-directed therapies such as poly(ADP-ribose) polymerase inhibitors…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨 #JCO #SpecialSeriesReview: 🥊Point 🥊Counterpoint ⚔️@MattYurgelun VS. ⚔️@HHampel1 💡Is it time for universal germline #GeneticTesting for all #GastrointestinalCancers❔ #GenCSM #CRCSM #ancsm #stcsm #hpbcsm #esocsm #gicsm https://t.co/uzt73vvATz https://t.co/El5g1lJdx1
-
-
Mashup Score: 0Anal Cancer: Emerging Standards in a Rare Rare Disease - 2 year(s) ago
The social stigma surrounding an anal cancer diagnosis has traditionally prevented open discussions about this disease. However, as recent treatment options and an increasing rate of diagnoses are made worldwide, awareness is growing. In the United States alone, 9,090 individuals were expected to be diagnosed with anal cancer in 2021. The US annual incidence of squamous cell carcinoma of the anus…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨 #JCO #SpecialSeriesReview: #AnalCancer is a rare malignancy w/ increased yearly incidence. 👀 Check out this summary of multidisciplinary approaches & impactful ongoing #ClinicalTrials: https://t.co/fAtT99jYrP #ancsm @cathyengmd https://t.co/cUOmraGOPq
-
-
Mashup Score: 7Anal Cancer Prevention (PDQ®)–Patient Version - 2 year(s) ago
Anal cancer prevention includes avoiding risk factors like the human papillomavirus (HPV) and taking protective steps like receiving the HPV vaccine. Learn more about preventing anal cancer in this expert-reviewed summary.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Did you know? Being infected with human papillomavirus (HPV) is the main risk factor for #AnalCancer. Studies show that being vaccinated against HPV lowers the risk of anal cancer: https://t.co/CooqmhlzWH #ANCSM https://t.co/lHeLLbeDvC
-
-
Mashup Score: 0Biomarker Testing for Anal Cancer - 2 year(s) ago
Cathy Eng, MD, discusses what can be done in order to integrate biomarker testing for anal cancer into clinical practice.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Cathy Eng, MD, discusses what can be done in order to integrate biomarker testing for anal cancer into clinical practice. #ancsm https://t.co/9EEDOkCWUT
-
-
Mashup Score: 1Ablating High-Grade Anal Lesions Thwarts Progression to Cancer - 2 year(s) ago
Screening followed by aggressive therapy shows benefit in phase III ANCHOR study
Source: www.medpagetoday.comCategories: Latest Headlines, Oncologists2Tweet-
A protocol in which high-grade squamous intraepithelial lesions of the anal canal were immediately treated was more effective for preventing incidence of anal cancer in people with HIV, a randomized trial found. @IAS_USA #CROI22 #ancsm https://t.co/eJxGtmLFVH
-
-
Mashup Score: 3Patient-Reported Outcomes Reveal People With Anal Cancer Experience High Stress, Decreased Quality of Life - 2 year(s) ago
New research on patient-reported outcomes has found that patients with anal cancer and survivors experience a decrease in quality of life as a result of high levels of cancer-related stress, including anxiety, stigma, and embarrassment (Abstract 2).
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Study by @TheRaymondOrg found 93% of patients w/ #analcancer report a decrease in quality of life, continual stigma & increased daily distress levels, leading to allostatic load. https://t.co/AuAF3YMNxy #GI22 #GICSM #ancsm
-
-
Mashup Score: 2
Purpose: A multi-institutional phase II trial assessed long-term outcomes of DP-IMRT with 5-fluorouracil (5FU) and mitomycin-C (MMC) for anal canal cancer.Patients and Methods: T2-4N0-3M0 anal cancers received 5FU (1000 mg/m2/day 96 hour infusion) and MMC (10 mg/m2 bolus) days 1 and 29 of DP-IMRT prescribed as – T2N0: 42Gy elective nodal and 50.4Gy anal tumor planning target volumes (PTVs), 28…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A nonrandomized phase II suggests that dose-painted IMRT with 5FU/MMC for anal cancer yields comparable long-term efficacy to conventional radiation, with lower rates of grade >/=3 late effects without compromising pelvic tumour control: https://t.co/FmqgUZzimj #ancsm #radonc
-
-
Mashup Score: 0The Role of Biomarker Testing in Anal Cancer - 3 year(s) ago
Cathy Eng, MD, FACO, FASCO, discusses how biomarkers are being explored to aid the treatment of anal cancers.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Cathy Eng, MD, FACO, FASCO, discusses how biomarkers are being explored to aid the treatment of anal cancers. #ancsm https://t.co/WbTBkUOAsx
-
-
Mashup Score: 1Boosting the Amount of Concurrent Chemoradiotherapy Administered to Patients With ASCC May Improve Efficacy - 3 year(s) ago
Increasing the dose of the primary treatment modality for anal squamous cell carcinoma, chemoradiotherapy, may further improve efficacy for patients with effective organ preservation and disease control.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Increasing the dose of the primary treatment modality for anal squamous cell carcinoma, chemoradiotherapy, may further improve efficacy for patients with effective organ preservation and disease control. #WorldGI2021 #ancsm https://t.co/rBEYDS5biz
-
A study by researchers from @OSUCCC_James finds substantial disparities in the management of stages I–III #analcancer based on age: https://t.co/753Or3lwo6 @Ansel_PhD @emilyhuangmd @Dr_Alessandra_G #ancsm #GeriOnc #ChemoRT #hsronc #HealthDisparities https://t.co/y0U3w2h4DQ